Johnson & Johnson Agrees to Pay $5.5 Billion to Resolve Talcum Powder Cancer Litigation
Johnson & Johnson (J&J) announced on July 27, 2026 that it had reached a proposed settlement to resolve approximately 76,000 talcum powder ovarian cancer lawsuits that had accumulated in federal and state courts over more than a decade of litigation. The company committed $5.5 billion toward the resolution, with its first payment not to exceed […]
Johnson & Johnson Liable for Nearly $1 Billion in Damages for Cancer-Causing Baby Powder
Earlier this month, a jury in Los Angeles, found Johnson & Johnson, Inc. (J&J) was liable for damages in the amount of $966 million dollars to the family of a long-time consumer of its baby talcum powder. The jury concluded that the pharmaceutical giant was liable for its dangerous talcum powder product which caused the […]
FDA Revokes EUA for Johnson & Johnson/Janssen’s COVID Vaccine
On June 1, 2023, the U.S. Food and Drug Administration (FDA) withdrew the Emergency Use Authorization (EUA) Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S (also known as JNJ-78436735) COVID-19 vaccine that had been granted to the companies on Feb. 27, 2021. The FDA noted that Janssen requested the voluntary withdrawal of the EUA in a letter […]
Doctors Link Shortage of Children’s Medications to Spike in Respiratory Infections
In the last few months, parents and caregivers of children have struggled to find over-the-counter and prescription medications used to treat common childhood illnesses like influenza, ear infections and sore throats for their sick children.1 2 The four medications reportedly in short supply are Amoxicillin (an antibiotic), Tamiflu (an antiviral), Albuterol (a bronchodilator) and children’s Tylenol […]
South Africa Confirms Second Guillain-Barré Syndrome Death Due to COVID Vaccine
The South African Health Products Regulatory Authority (SAHPRA) confirmed on Sept. 12, 2022 that another person in South Africa has died of a polio-like neurological disorder that causes paralysis known as Guillain-Barré syndrome (GBS) due to receiving Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S COVID-19 vaccine. SAHPRA said the National Immunization Safety Expert Committee (NISEC) performed […]
Death in South Africa Causally Linked to Johnson & Johnson COVID Vaccine
On Aug. 4, 2022, the South African Health Products Regulatory Authority (SAHPRA) reported the death of an individual in South Africa shortly after receiving Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S COVID-19 vaccine. The agency stated that the death was causally linked to the vaccine.1 2 3 4 5 The name and age of the person […]